BioCentury
ARTICLE | Company News

Centocor cardiovascular news

June 7, 1999 7:00 AM UTC

CNTO said it expects that suits brought against it by Genentech Inc. (GNE, South San Francisco, Calif.) relating to CNTO's Retavase reteplase tPA will be dropped following the acquisition of GNE by...